Skip to Content

Tag: Inspire


News

In brief: F&P upgrades guidance, NSM creates 'Chill Spot'

August 30, 2019HME News Staff

IRVINE, Calif. - Fisher & Paykel Healthcare has upgraded its guidance for the financial year ending March 31, 2020, to full operating revenue of about $1.17 billion and net profit after tax of about $245 million to $255 million.The company expects operating revenue for the first half of the 2020 financial year ending Sept. 30, 2019, to be about NZ$560 million and net profit after tax to be about NZ$120 million.“We've had a good start to the year and are on track to deliver strong revenue and...

Fisher & Paykel, Inspire, NSM, ResMed, Responsive Respiratory


Read Full Articlered right arrow icon

Also Noted

Inspire touts coverage win

August 27, 2019HME News Staff

MINNEAPOLIS - Two Medicare Administrative Contractors, Noridian and Palmetto, have published draft local coverage determinations that propose coverage for Inspire Medical Systems' obstructive sleep apnea therapy, according to the company. Both draft LCDs state that for individuals with OSA who are treated with hypoglossal nerve stimulation, the evidence is sufficient to determine that neurostimulation technology results in a meaningful improvement in the net health outcomes when used as outlined....

coverage, Inspire, Sleep Therapy


Read Full Articlered right arrow icon

Also Noted

Inspire touts therapy specifically for Medicare patients

May 17, 2019Theresa Flaherty, Managing Editor

MINNEAPOLIS - Inspire Medical Systems has announced the results of a study that shows Medicare-aged patients, in particular, respond well to and adhere to its therapy. The study, led by physicians at the University of Alabama at Birmingham, followed 235 Medicare-aged patients and 365 younger-aged patients and collected information on sleep apnea severity, quality of life and any complications with the procedure. The results demonstrated that, while all patients positively responded to Inspire therapy,...

CPAP Alternative, Inspire, study


Read Full Articlered right arrow icon

News

In brief: Arriva Medical execs settle lawsuit, trustees expect Part B costs to grow

April 26, 2019HME News Staff

NASHVILLE, Tenn. - Two former Arriva Medical executives have agreed to pay $500,000 each to settle allegations they violated the False Claims Act.The settlement resolves the U.S.'s claims that David Wallace and Timothy Stocksdale caused Arriva to submit claims to Medicare that were tainted by kickbacks paid to beneficiaries in the form of free or no cost home blood glucose meters, or waived or uncollected copayments from Nov. 23, 2011, through Aug. 30, 2013.The settlement also resolves the U.S.'s...

Arriva Medical, iLevel, Inspire


Read Full Articlered right arrow icon